*Evaluating the effect of qualitative feedback on asthma control in adults with difficult to treat asthma by improving therapy adherence and inhalation technique*
Withdrawn
- Conditions
- asthmabronchospasms10010613
- Registration Number
- NL-OMON48192
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 68
Inclusion Criteria
- Patients from 18 years or older.
- Patients who suffer from difficult to treat asthma.
- Patients are under treatment in MST
Exclusion Criteria
- Patients who are unable to speak or understand the Dutch language.
- Current smokers
- Patients who are not compatible with the medication delivered through the
Nexthaler, Ellipta or Spiromax. Switch between dosis aerosol and dry powder
inhaler device is allowed if the medication remains the same. Patients should
use this device at least a month before entering the study.
- Patients with a chronic disease other than asthma that can influence the lung
function.
- Patients who use a biological drug for their asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameter is clinical improvement in asthma control in patients<br /><br>with difficult to treat asthma between phase 1 and phase 2 and the course of<br /><br>asthma control in phase 3. Clinical improvement in asthma control is assessed<br /><br>by a lung function test, the ACQ score and the AQLQ score.</p><br>
- Secondary Outcome Measures
Name Time Method